Thursday 17th July 2008 |
Text too small? |
The group agreed to the acquisition subject to due diligence and approval of shareholders of Allco HIT, which is selling Strategic Finance's immediately parent.
Strategic Finance's current owners were "unable to assist in providing the necessary capital we need to run the business and move forward," Finnigan said in a BusinessWire interview.
Helping cement the transaction, BOS has agreed to support a NZ$150 million wholesale lending facility, reducing the percentage of funding generated from the sale of debentures. The deal would make Strategic Finance, along with ANZ Bank's ING unit, one of the few New Zealand finance companies with a bank as a shareholder, Finnigan said. "It positions us very well for the future," he said.
Strategic Finance last month said it was undertaking "an intensive review of its business" covering provisioning, liquidity and doubtful debt levels.
The company had assets of NZ$568 million at June 30, with debentures at NZ$320 million.
"The renewal rate is definitely down," Finnigan said. It dropped as low as 20% and is currently 35% to 40%, he said.
BOS will have an initial 19.9% cornerstone and the ability to increase to 49% to reflect its financial contribution to the group, the statement said. The original owners and senior managers will hold the balance.
The group includes Graham Jackson, Jock Hobbs and Marc Lindale who are all executive directors of Strategic Finance
Finnigan said despite the difficulties facing the New Zealand finance company sector, the proposed ownership change of Strategic Finance should ensure its long-term future.
"History has shown that the need for strong finance companies in New Zealand will not disappear," he said. "We have every confidence that the change of ownership will ensure that Strategic Finance will be one of the companies servicing this need."
The sale process is expected to take two months.
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors